/IDEXX%20sign%20at%20their%20offices%20in%20Silicon%20Valley_%20By%20Sundry%20Photography.jpeg)
Based in Westbrook, Maine, IDEXX Laboratories, Inc. (IDXX) is a global healthcare company specializing in diagnostic products and software for veterinary practices. It provides testing solutions for pets, livestock, poultry, dairy, and horses, alongside water quality testing and diagnostic systems for human medicine. The company has a market capitalization of $41 billion.
IDXX is scheduled to report its Q3 earnings on Monday, November 2, 2026, before the market opens. Ahead of the release, analysts expect diluted EPS of $3.70, up 8.8% from $3.40 in the year-ago quarter. IDXX has also exceeded Wall Street’s EPS estimates in each of the past four quarters, highlighting its consistent earnings performance.
